LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods.

    Metanat, Yekta / Viktor, Patrik / Amajd, Ayesha / Kaur, Irwanjot / Hamed, Ashraf Mohammed / Abed Al-Abadi, Noor K / Alwan, Nathera Hussin / Chaitanya, M V N L / Lakshmaiya, Natrayan / Ghildiyal, Pallavi / Khalaf, Othman Mahjoob / Ciongradi, Carmen Iulia / Sârbu, Ioan

    Life sciences

    2024  Volume 348, Page(s) 122683

    Abstract: Although CAR-T cell therapy has emerged as a game-changer in cancer immunotherapy several bottlenecks limit its widespread use as a front-line therapy. Current protocols for the production of CAR-T cells rely mainly on the use of lentiviral/retroviral ... ...

    Abstract Although CAR-T cell therapy has emerged as a game-changer in cancer immunotherapy several bottlenecks limit its widespread use as a front-line therapy. Current protocols for the production of CAR-T cells rely mainly on the use of lentiviral/retroviral vectors. Nevertheless, according to the safety concerns around the use of viral vectors, there are several regulatory hurdles to their clinical use. Large-scale production of viral vectors under "Current Good Manufacturing Practice" (cGMP) involves rigorous quality control assessments and regulatory requirements that impose exorbitant costs on suppliers and as a result, lead to a significant increase in the cost of treatment. Pursuing an efficient non-viral method for genetic modification of immune cells is a hot topic in cell-based gene therapy. This study aims to investigate the current state-of-the-art in non-viral methods of CAR-T cell manufacturing. In the first part of this study, after reviewing the advantages and disadvantages of the clinical use of viral vectors, different non-viral vectors and the path of their clinical translation are discussed. These vectors include transposons (sleeping beauty, piggyBac, Tol2, and Tc Buster), programmable nucleases (ZFNs, TALENs, and CRISPR/Cas9), mRNA, plasmids, minicircles, and nanoplasmids. Afterward, various methods for efficient delivery of non-viral vectors into the cells are reviewed.
    Language English
    Publishing date 2024-05-01
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2024.122683
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice.

    Wang, Hui / Jayasankar, Narayanan / Thamaraikani, Tamilanban / Viktor, Patrik / Mohany, Mohamed / Al-Rejaie, Salim S / Alammar, Hasan Khalid / Anad, Enaam / Alhili, Farah / Hussein, Sinan F / Amin, Ali H / Lakshmaiya, Natrayan / Ahsan, Muhammad / Bahrami, Abolfazl / Akhavan-Sigari, Reza

    publication RETRACTED

    Life sciences

    2024  Volume 340, Page(s) 122449

    Abstract: Aims: Cognitive impairment poses a considerable health challenge in the context of type 2 diabetes mellitus (T2DM), emphasizing the need for effective interventions. This study delves into the therapeutic efficacy of quercetin, a natural flavonoid, in ... ...

    Abstract Aims: Cognitive impairment poses a considerable health challenge in the context of type 2 diabetes mellitus (T2DM), emphasizing the need for effective interventions. This study delves into the therapeutic efficacy of quercetin, a natural flavonoid, in mitigating cognitive impairment induced by T2DM in murine models.
    Materials and methods: Serum exosome samples were obtained from both T2DM-related and healthy mice for transcriptome sequencing, enabling the identification of differentially expressed mRNAs and long noncoding RNAs (lncRNAs). Subsequent experiments were conducted to ascertain the binding affinity between mmu-miR-129-5p, NEAT1 and BDNF. The structural characteristics and dimensions of isolated exosomes were scrutinized, and the expression levels of exosome-associated proteins were quantified. Primary mouse hippocampal neurons were cultured for in vitro validation, assessing the expression of pertinent genes as well as neuronal vitality, proliferation, and apoptosis capabilities. For in vivo validation, a T2DM mouse model was established, and quercetin treatment was administered. Changes in various parameters, cognitive ability, and the expression of insulin-related proteins, along with pivotal signaling pathways, were monitored.
    Key findings: Analysis of serum exosomes from T2DM mice revealed dysregulation of NEAT1, mmu-miR-129-5p, and BDNF. In vitro investigations demonstrated that NEAT1 upregulated BDNF expression by inhibiting mmu-miR-129-5p. Overexpression of mmu-miR-129-5p or silencing NEAT1 resulted in the downregulation of insulin-related protein expression, enhanced apoptosis, and suppressed neuronal proliferation. In vivo studies validated that quercetin treatment significantly ameliorated T2DM-related cognitive impairment in mice.
    Significance: These findings suggest that quercetin holds promise in inhibiting hippocampal neuron apoptosis and improving T2DM-related cognitive impairment by modulating the NEAT1/miR-129-5p/BDNF pathway within serum exosomes.
    MeSH term(s) Animals ; Mice ; RNA, Long Noncoding/genetics ; RNA, Long Noncoding/metabolism ; Quercetin/pharmacology ; Brain-Derived Neurotrophic Factor/genetics ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Experimental/complications ; Cell Proliferation/genetics ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/genetics ; Insulins
    Chemical Substances RNA, Long Noncoding ; Quercetin (9IKM0I5T1E) ; Brain-Derived Neurotrophic Factor ; MicroRNAs ; Insulins
    Language English
    Publishing date 2024-01-20
    Publishing country Netherlands
    Document type Journal Article ; Retracted Publication
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2024.122449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Retraction notice to "Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice" [Life Sci. 340 (2024) 122449].

    Wang, Hui / Jayasankar, Narayanan / Thamaraikani, Tamilanban / Viktor, Patrik / Mohany, Mohamed / Al-Rejaie, Salim S / Alammar, Hasan Khalid / Anad, Enaam / Alhili, Farah / Hussein, Sinan F / Amin, Ali H / Lakshmaiya, Natrayan / Ahsan, Muhammad / Bahrami, Abolfazl / Akhavan-Sigari, Reza

    Life sciences

    2024  Volume 347, Page(s) 122679

    Language English
    Publishing date 2024-05-01
    Publishing country Netherlands
    Document type Journal Article ; Retraction of Publication
    ZDB-ID 3378-9
    ISSN 1879-0631 ; 0024-3205
    ISSN (online) 1879-0631
    ISSN 0024-3205
    DOI 10.1016/j.lfs.2024.122679
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.

    Chehelgerdi, Mohammad / Chehelgerdi, Matin / Allela, Omer Qutaiba B / Pecho, Renzon Daniel Cosme / Jayasankar, Narayanan / Rao, Devendra Pratap / Thamaraikani, Tamilanban / Vasanthan, Manimaran / Viktor, Patrik / Lakshmaiya, Natrayan / Saadh, Mohamed J / Amajd, Ayesha / Abo-Zaid, Mabrouk A / Castillo-Acobo, Roxana Yolanda / Ismail, Ahmed H / Amin, Ali H / Akhavan-Sigari, Reza

    Molecular cancer

    2023  Volume 22, Issue 1, Page(s) 169

    Abstract: The use of nanotechnology has the potential to revolutionize the detection and treatment of cancer. Developments in protein engineering and materials science have led to the emergence of new nanoscale targeting techniques, which offer renewed hope for ... ...

    Abstract The use of nanotechnology has the potential to revolutionize the detection and treatment of cancer. Developments in protein engineering and materials science have led to the emergence of new nanoscale targeting techniques, which offer renewed hope for cancer patients. While several nanocarriers for medicinal purposes have been approved for human trials, only a few have been authorized for clinical use in targeting cancer cells. In this review, we analyze some of the authorized formulations and discuss the challenges of translating findings from the lab to the clinic. This study highlights the various nanocarriers and compounds that can be used for selective tumor targeting and the inherent difficulties in cancer therapy. Nanotechnology provides a promising platform for improving cancer detection and treatment in the future, but further research is needed to overcome the current limitations in clinical translation.
    MeSH term(s) Humans ; Neoplasms/diagnosis ; Neoplasms/drug therapy ; Nanotechnology/methods ; Drug Delivery Systems/methods ; Drug Carriers ; Drug Compounding ; Nanoparticles
    Chemical Substances Drug Carriers
    Language English
    Publishing date 2023-10-09
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2091373-4
    ISSN 1476-4598 ; 1476-4598
    ISSN (online) 1476-4598
    ISSN 1476-4598
    DOI 10.1186/s12943-023-01865-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top